Lifirafenib, CAS 1446090-79-4

Product Description: Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively.

Applications: Cancer-Kinase/protease

Formula: C25H17F3N4O3

References: [1]Tang Z, et al. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers. Mol Cancer Ther. 2015 Oct;14(10):2187-97.

CAS Number: 1446090-79-4

Molecular Weight: 478.42

Compound Purity: 98.73

Research Area: Cancer

Solubility: DMSO : ≥ 100 mg/mL

Target: EGFR;Raf

• Artikelnummer: MEXHY-18957-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-18957-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK